Journal of Hepatology
Volume 52, Issue 2 , Pages 228-233 , February 2010

A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer

  • He Wen

      Affiliations

    • Department of Biochemistry, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University, Shinheung-dong, Chung-gu, Incheon 400-712, Republic of Korea
    • These authors contributed equally to this work.
    • ,
  • Sung Soo Yoo

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University, Incheon, Republic of Korea
    • These authors contributed equally to this work.
    • ,
  • Jinho Kang

      Affiliations

    • Department of Biochemistry, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University, Shinheung-dong, Chung-gu, Incheon 400-712, Republic of Korea
    • ,
  • Hee Goo Kim

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University, Incheon, Republic of Korea
    • ,
  • Jin-Seok Park

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University, Incheon, Republic of Korea
    • ,
  • Seok Jeong

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University, Incheon, Republic of Korea
    • ,
  • Jung Il Lee

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University, Incheon, Republic of Korea
    • ,
  • Hyuk Nam Kwon

      Affiliations

    • Department of Biochemistry, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University, Shinheung-dong, Chung-gu, Incheon 400-712, Republic of Korea
    • ,
  • Sunmi Kang

      Affiliations

    • Department of Biochemistry, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University, Shinheung-dong, Chung-gu, Incheon 400-712, Republic of Korea
    • ,
  • Don-Haeng Lee

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University, Incheon, Republic of Korea
    • Corresponding Author InformationCorresponding authors. Tel.: +82 32 8902548; fax: +82 32 8902549 (D.-H. Lee); Tel.: +82 32 8900935; fax: +82 32 8846726 (S. Park).
    • ,
  • Sunghyouk Park

      Affiliations

    • Department of Biochemistry, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University, Shinheung-dong, Chung-gu, Incheon 400-712, Republic of Korea
    • Corresponding Author InformationCorresponding authors. Tel.: +82 32 8902548; fax: +82 32 8902549 (D.-H. Lee); Tel.: +82 32 8900935; fax: +82 32 8846726 (S. Park).

Received 14 April 2009 ,Revised 27 August 2009 ,Accepted 1 September 2009.

References 

  1. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353–1357
  2. El Rassi ZE, Partensky C, Scoazec JY, Henry L, Lombard-Bohas C, Maddern G. Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol. 1999;25:375–380
  3. Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998. Gut. 2001;48:816–820
  4. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10
  5. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89:1525–1531
  6. Ueno N, Sano T, Kanamaru T, Tanaka K, Nishihara T, Idei Y, et al. Adenosquamous cell carcinoma arising from the papilla major. Oncol Rep. 2002;9:317–320
  7. Saito M, Hige S, Takeda H, Tomaru U, Shibata M, Asaka M. Combined hepatocellular carcinoma and cholangiocarcinoma growing into the common bile duct. J Gastroenterol. 2001;36:842–847
  8. Matsumoto A, Imamura M, Akagi Y, Kaibara A, Ohkita A, Mizobe T, et al. A case report of disseminated recurrence of inferior bile duct carcinoma in PTCD fistula. Kurume Med J. 2002;49:71–75
  9. Siqueira E, Schoen RE, Silverman W, Martin J, Rabinovitz M, Weissfeld JL, et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc. 2002;56:40–47
  10. Steinberg W. The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol. 1990;85:350–355
  11. Perkins GL, Slater ED, Sanders GK, Prichard JG. Serum tumor markers. Am Fam Physician. 2003;68:1075–1082
  12. Qin XL, Wang ZR, Shi JS, Lu M, Wang L, He QR. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA. World J Gastroenterol. 2004;10:427–432
  13. Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Haglund C. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 2002;22:2311–2316
  14. Bjornsson E, Kilander A, Olsson R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver. 1999;19:501–508
  15. Davidson B, Varsamidakis N, Dooley J, Deery A, Dick R, Kurzawinski T, et al. Value of exfoliative cytology for investigating bile duct strictures. Gut. 1992;33:1408–1411
  16. Osnes M, Serck-Hanssen A, Myren J. Endoscopic retrograde brush cytology (ERBC) of the biliary and pancreatic ducts. Scand J Gastroenterol. 1975;10:829–831
  17. de Bellis M, Fogel EL, Sherman S, Watkins JL, Chappo J, Younger C, et al. Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction. Gastrointest Endosc. 2003;58:176–182
  18. Kurzawinski T, Deery A, Davidson BR. Diagnostic value of cytology for biliary stricture. Br J Surg. 1993;80:414–421
  19. Logrono R, Kurtycz DF, Molina CP, Trivedi VA, Wong JY, Block KP. Analysis of false-negative diagnoses on endoscopic brush cytology of biliary and pancreatic duct strictures: the experience at 2 university hospitals. Arch Pathol Lab Med. 2000;124:387–392
  20. Mahmoudi N, Enns R, Amar J, AlAli J, Lam E, Telford J. Biliary brush cytology: factors associated with positive yields on biliary brush cytology. World J Gastroenterol. 2008;14:569–573
  21. Vandervoort J, Soetikno RM, Montes H, Lichtenstein DR, Van Dam J, Ruymann FW, et al. Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct. Gastrointest Endosc. 1999;49:322–327
  22. Kim HJ, Kim MH, Myung SJ, Lim BC, Park ET, Yoo KS, et al. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol. 1999;94:1941–1946
  23. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2002;8:1439–1444
  24. Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 2004;22:245–252
  25. Claudino WM, Quattrone A, Biganzoli L, Pestrin M, Bertini I, Di Leo A. Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol. 2007;25:2840–2846
  26. Park SY, Park CH, Cho SB, Yoon KW, Lee WS, Kim HS, et al. The safety and effectiveness of endoscopic biliary decompression by plastic stent placement in acute suppurative cholangitis compared with nasobiliary drainage. Gastrointest Endosc. 2008;68:1076–1080
  27. Kang J, Choi MY, Kang S, Kwon HN, Wen H, Lee CH, et al. Application of a 1H nuclear magnetic resonance (NMR) metabolomics approach combined with orthogonal projections to latent structure-discriminant analysis as an efficient tool for discriminating between Korean and Chinese herbal medicines. J Agric Food Chem. 2008;56:11589–11595
  28. Kang J, Lee S, Kang S, Kwon HN, Park JH, Kwon SW, et al. NMR-based metabolomics approach for the differentiation of ginseng (Panax ginseng) roots from different origins. Arch Pharm Res. 2008;31:330–336
  29. Kim K, Aronov P, Zakharkin SO, Anderson D, Perroud B, Thompson IM, et al. Urine metabolomic analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics. 2009;8:558–570
  30. Wiklund S, Johansson E, Sjostrom L, Mellerowicz EJ, Edlund U, Shockcor JP, et al. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem. 2008;80:115–122
  31. Cloarec O, Dumas ME, Craig A, Barton RH, Trygg J, Hudson J, et al. Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal Chem. 2005;77:1282–1289
  32. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463–473discussion 473–465
  33. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the gallbladder: histologic types, stage of disease, grade, and survival rates. Cancer. 1992;70:1493–1497
  34. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the extrahepatic bile ducts: histologic types, stage of disease, grade, and survival rates. Cancer. 1992;70:1498–1501
  35. Farley DR, Weaver AL, Nagorney DM. “Natural history” of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc. 1995;70:425–429
  36. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999;341:1368–1378
  37. Park SW, Song SY, Chung JB, Jung BG, Moon YM, Kang JK, et al. Combined endoscopic transpapillary biopsy and exfoliative cytology for the diagnosis of bile duct cancer. Korean J Gastrointest Endosc. 1999;19:588–596
  38. Wang JN, Zhou Y, Zhu TY, Wang X, Guo YL. Prediction of acute cellular renal allograft rejection by urinary metabolomics using MALDI-FTMS. J Proteome Res. 2008;7:3597–3601

PII: S0168-8278(09)00728-4

doi: 10.1016/j.jhep.2009.11.002

Journal of Hepatology
Volume 52, Issue 2 , Pages 228-233 , February 2010

Article Tools

* Image Usage & Resolution